Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bradley Pharmaceuticals has announced that its Doak Dermatologics subsidiary has launched Rosula CLK, a kit combining two topical skincare products currently marketed by Doak.
Subscribe to our email newsletter
The kit contains Rosula Clarifying Wash (sodium sulfacetamide 10% and sulfur 4%) in a urea vehicle, and A-FIL Cream (meradimate 5% and titanium dioxide 5%) sunscreen.
Rosula Clarifying Wash is a cleanser indicated for the treatment of acne vulgaris, acne rosacea and seborrheic dermatitis. A-FIL Cream is an opaque SPF-25 dual barrier sunscreen that reflects and absorbs ultraviolet rays.
Daniel Glassman, president and CEO of Bradley, said: “The American Academy of Dermatology advises patients who suffer from acne vulgaris and acne rosacea to protect their skin using a broad-spectrum sunscreen with an SPF of 15 or higher. We feel that the combination of Rosula Clarifying Wash and A-FIL brand sunscreen will allow patients to more easily follow this important treatment and skin care regimen and enhance patient care.”